AVITA Medical (RCEL) Research & Development (2018 - 2025)
AVITA Medical (RCEL) posted Research & Development of $11.9 million for Q4 2025, up 218.52% on a QoQ basis from $3.7 million in Q3 2025, and up 146.14% year-over-year from $4.8 million in Q4 2024.
AVITA Medical (RCEL) Research & Development (2018 - 2025) Analysis & Trends
AVITA Medical's Research & Development history runs 8 years deep, the most recent figure standing at $11.9 million for Q4 2025.
- Quarterly Research & Development rose 146.14% year-over-year to $11.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.3 million (up 2320.55% YoY) and the FY2025 annual result came in at $53.1 million, up 160.99% from the prior year.
- Research & Development was $11.9 million for Q4 2025 at AVITA Medical, up from $3.7 million in the prior quarter.
- Across five years, Research & Development topped out at $14.3 million in Q2 2025 and bottomed at -$13.4 million in Q3 2024.
- A 5-year average of $5.8 million and a median of $5.3 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2021 — Research & Development jumped 246.49% — and 2024, when it tumbled 405.69%.
- AVITA Medical's Research & Development stood at $11.3 million in 2021, then gained by 1.08% to $11.4 million in 2022, then sank by 40.84% to $6.8 million in 2023, then declined by 28.31% to $4.8 million in 2024, then soared by 146.14% to $11.9 million in 2025.
- Business Quant data shows RCEL's Research & Development at $11.9 million in Q4 2025, $3.7 million in Q3 2025, and $14.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 11.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 14.31 Mn |
| Mar 31, 2025 | 6.28 Mn |
| Dec 31, 2024 | 4.85 Mn |
| Sep 30, 2024 | -13.43 Mn |
| Jun 30, 2024 | 4.89 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 4.39 Mn |
| Jun 30, 2023 | 5.08 Mn |
| Mar 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 11.44 Mn |
| Sep 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 4.83 Mn |
| Sep 30, 2021 | 11.31 Mn |
| Jun 30, 2021 | 8.08 Mn |
| Mar 31, 2021 | 3.65 Mn |
| Dec 31, 2020 | 3.36 Mn |
| Sep 30, 2020 | 3.27 Mn |